Andreasen T L
Thromb Haemost. 1980 Dec 19;44(3):135-7.
Antithrombin III (At-III) was measured at the time of admission and two days later in 131 patients laid up in a coronary care unit. The patients were examined for deep-vein thrombosis (DVT) clinically and by means of 125I-fibrinogen scanning. 19 patients developed DVT. In 11 subjects with and 25 without DVT At-III decreased more than 10%. And in 7 with and 17 without DVT At-III decreased more than 15%. One person with DVT had subnormal At-III. By using decrease of At-III or subnormal initial At-III to predict DVT the following predictive value (PV) were found. Decrease less than or equal to 10%, PV pos. = 0.32 and PV neg. = 0.93. Decrease less than or equal to 15%, PV pos. = 0.32 and PV neg. = 0.90. The positive predictive values obtained were too low to let decreasing At-III give occasion for prophylactic anticoagulant treatment.
对131名入住冠心病监护病房的患者在入院时及两天后测定了抗凝血酶III(At-III)。对患者进行了深静脉血栓形成(DVT)的临床检查及125I-纤维蛋白原扫描。19名患者发生了DVT。在11名发生DVT和25名未发生DVT的受试者中,At-III下降超过10%。在7名发生DVT和17名未发生DVT的受试者中,At-III下降超过15%。1名发生DVT的患者At-III低于正常水平。通过使用At-III下降或初始At-III低于正常水平来预测DVT,发现了以下预测值(PV)。下降小于或等于10%,PV阳性=0.32,PV阴性=0.93。下降小于或等于15%,PV阳性=0.32,PV阴性=0.90。所获得的阳性预测值过低,以至于At-III下降不能作为预防性抗凝治疗的依据。